Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19
This randomized trial compares the effects of ivermectin vs placebo on time to symptom resolution within 21 days among patients with mild COVID-19.
This randomized trial compares the effects of ivermectin vs placebo on time to symptom resolution within 21 days among patients with mild COVID-19.
This Viewpoint advocates for the addition of clozapine prescribing as a milestone in psychiatric education.
This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.
A man with a history of polysubstance use presents with new bullae on his bilateral lower extremities. What is your diagnosis?
This Viewpoint examines whether overdiagnosis rather than underdiagnosis may now be the dominant form of myocardial infarction misdiagnosis.
This cross-sectional study investigates the association between cardiometabolic disease prevalence in the US and deep learning–based assessment of the built environment from satellite imagery.
This cohort study explores whether a novel artificial intelligence (AI) video-based biomarker for aortic stenosis is associated with development and progression of aortic stenosis.
This survey study reports on use of renal replacement therapy, hemodynamic support, sedation, neuroimaging, and extracorporeal membrane oxygenation at Renal Anhydramnios Fetal Therapy trial sites…
This cross-sectional study evaluates emergency department visits for physical injuries from use of conducted energy devices by police departments.
This cross-sectional study investigates the stroke burden trends in the US in 2019 and how they evolved from 1990 to 2019 with a focus on…
This cross-sectional study evaluates the use of the US Food and Drug Administration’s Real-Time Oncology Review (RTOR) program in confirming the effectiveness of cancer drugs.